NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.75M | -54.66M | -55.84M | -58.01M | -60.93M |
| Total Depreciation and Amortization | 1.45M | 1.81M | 2.19M | 2.49M | 2.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.18M | 2.26M | 3.09M | 3.93M | 4.56M |
| Change in Net Operating Assets | -2.87M | 605.00K | 954.00K | 2.64M | -426.00K |
| Cash from Operations | -36.98M | -49.98M | -49.61M | -48.94M | -54.13M |
| Capital Expenditure | -- | -- | -- | 34.00K | -136.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.79M | 19.76M | 25.56M | 26.48M | 36.25M |
| Cash from Investing | 25.79M | 19.76M | 25.56M | 26.51M | 36.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.79M | 24.78M | 23.54M | 2.06M | 2.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.22M | -1.22M | -1.22M | -- | -- |
| Cash from Financing | 21.56M | 23.56M | 22.31M | 2.06M | 2.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.37M | -6.66M | -1.75M | -20.38M | -15.96M |